1 unchanged sentence
Regis common stock is listed and traded on the New York Stock Exchange under the symbol "RGS."
−Removed: As of August 9, 2019 , Regis shares were owned by approximately 10,000 shareholders based on the number of record holders and an estimate of individual participants in security position listings.
+Added: As of August 14, 2020, Regis had approximately 1,200 shareholders of record.
The closing stock price was $9.31 per share on August 14, 2020.
10 unchanged sentences
Assumes Initial Investment of $100
+Added: June 30, 2020
+Added: 2015 2016 2017 2018 2019 2020
+Added: Regis $ 100.00 $ 79.00 $ 65.16 $ 104.95 $ 105.33 $ 51.90
+Added: S & P 500 100.00 103.99 122.60 140.23 154.83 166.45
S & P 400 Midcap 100.00 101.33 120.14 136.37 138.22 128.97
Dow Jones Consumer Services Index 100.00 101.83 118.10 141.21 160.76 172.15
+Added: Peer Group 100.00 105.05 110.14 110.55 125.61 89.82
In May 2000, the Company's Board of Directors (Board) approved a stock repurchase program with no stated expiration date.
2 unchanged sentences
The timing and amounts of any repurchases depends on many factors, including the market price of the common stock and overall market conditions.
−Removed: As of June 30, 2019 , 28.5 million shares have been cumulatively repurchased for $569.1 million , and $80.9 million remained outstanding under the approved stock repurchase program.
+Added: As of June 30, 2020, 30.0 million shares have been cumulatively repurchased for $595.4 million, and $54.6 million shares remained outstanding under the approved stock repurchase program.
The Company repurchased the following common stock through its share repurchase program:
+Added: 2020 2019 2018
Repurchased Shares 1,504,000 8,605,430 1,469,057
1 unchanged sentence
Price range (per share) $16.25 - $18.49 $15.29 - $19.75 $15.55 - $17.90
−Removed: $15.29 - $19.75
−Removed: $15.55 - $17.90
−Removed: $154.4 million
−Removed: $24.8 million
+Added: Total $26.4 million $154.4 million $24.8 million
The following table shows the stock repurchase activity by the Company or any “affiliated purchaser” of the Company, as defined in Rule 10b-18(a)(3) under the Exchange Act, by month for the three months ended June 30, 2020:
−Removed: Total Number of Shares Purchased
−Removed: Average Price Paid per Share
−Removed: Total Number of Shares Purchased As Part of Publicly Announced Plans or Programs
−Removed: Approximate Dollar Value of Shares that May Yet Be Purchased under the Plans or Programs (in thousands)
+Added: Period Total Number of Shares Purchased Average Price Paid per Share Total Number of Shares Purchased As Part of Publicly Announced Plans or Programs Approximate Dollar Value of Shares that May Yet Be Purchased under the Plans or Programs (in thousands)
4/1/20 - 4/30/20 — $ — 29,974,657 $ 54,573
1 unchanged sentence
6/1/20 - 6/30/20 — — 29,974,657 54,573
+Added: Total — $ — 29,974,657 $ 54,573
Selected Financial Data
1 unchanged sentence
All periods presented reflect the mall-based business and International segment as a discontinued operation.
−Removed: The following table sets forth selected financial data derived from the Company's Consolidated Financial Statements in Part II, Item 8.
−Removed: The table should be read in conjunction with Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations", and Item 8, "Financial Statements and Supplementary Data", of this Report on Form 10-K.
+Added: The following table sets forth selected financial data derived from the Company's Consolidated Financial Statements in Part II, Item 8 of this Form 10-K.
+Added: The table should be read in conjunction with Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" and Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.
+Added: 2020 2019 2018 2017 2016
(Dollars in thousands, except per share data)
−Removed: Operating (loss) income (a)
−Removed: (Loss) income from continuing operations(a)
+Added: Revenues $ 669,729 $ 1,069,039 $ 1,235,479 $ 1,292,800 $ 1,314,762
+Added: Operating (loss) income (1) (145,338) (22,119) (5,139) 12,550 21,865
+Added: (Loss) income from continuing operations (1) (172,194) (20,122) 59,621 (3,295) (8,085)
(Loss) income from continuing operations per diluted share $ (4.79) $ (0.48) $ 1.27 $ (0.07) $ (0.17)
+Added: 2020 2019 2018 2017 2016
(Dollars in thousands)
3 unchanged sentences
(1) The following significant items affected each of the years presented:
−Removed: During fiscal year 2019, the Company recorded a $21.8 million restructuring charge related to TBG mall locations (See Note 3 to the Consolidated Financial Statements), $4.6 million of non-cash fixed asset impairment charges and $2.9 million of net gain on salons sold to franchisees.
+Added: • During fiscal year 2020, the Company recorded a $40.2 million non-cash goodwill impairment charge, a $22.6 million non-cash long-lived asset impairment charge (See Note 1 to the Consolidated Financial Statements in Part II, Item 8, of this form 10-K), a loss on the sale of salons to franchisees of $27.3 million and the results were materially impacted by the COVID-19 pandemic.
+Added: • During fiscal year 2019, the Company recorded a $21.8 million restructuring charge related to TBG mall locations (See Note 3 to the Consolidated Financial Statements in Part II, Item 8, of this form 10-K), $4.6 million of non-cash fixed asset impairment charges and $2.9 million of net gain on salons sold to franchisees.
• During fiscal year 2018, the Company recorded a $68.1 million income tax benefit resulting from the federal rate reduction and a partial release of the U.S.
2 unchanged sentences
• During fiscal year 2016, the Company recorded a $13.0 million other than temporary non-cash impairment charge to fully impair its investment in EEG, $10.5 million of non-cash fixed asset impairment charges and $7.9 million of non-cash tax expense related to tax benefits on certain indefinite-lived assets that the Company cannot recognize for reporting purposes.
−Removed: During fiscal year 2015, the Company recorded its share of a non-cash deferred tax asset valuation allowance recorded by EEG of $6.9 million, non-cash other than temporary impairment charges of its investment in EEG of $4.7 million, $7.9 million of non-cash fixed asset impairment charges, $8.9 million of non-cash tax expense related to tax benefits on certain indefinite-lived assets that the Company cannot recognize for reporting purposes and established a non-cash $2.1 million valuation allowance against its Canadian deferred tax assets.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.